fda warning letters compounded semaglutide october 2025 alerts health care providers, compounders and patients of dosing errors associated with injectable products Compounded "semaglutide" is not FDA-approved

History of Semaglutide and Phentermine Semaglutide was developed by Novo Nordisk as a treatment for type 2 diabetes and marketed as Ozempic in 2017, followed by an oral form called Rybelsus in 2019

Too little sleep mimics brain fog, but underlying conditions that cause brain fog may also make it more difficult to sleep

Ghrelin levels decrease after eating, but certain foods, such as sugary drinks, may not suppress them effectively, leading to continued hunger

adults do not get the recommended amount of exercise

Cardiovasc Diabetol 16(1):143 Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC et al (2003) Pulse pressure and endothelial dysfunction in never-treated hypertensive patients